Dr. Robert James Sollaccio, MD

Dr. Sollaccio practices at Peninsula Radiation Oncology Center in Palmer, Alaska.

Dr. Sollaccio's NPI, 1942202981, was assigned on August 10, 2005. Dr. Sollaccio graduated from University Of Florida College Of Medicine in 1985. Dr. Sollaccio holds Florida license ME56371.

Dr. Sollaccio's primary practice is Peninsula Radiation Oncology Center, at 2250 S Woodworth Loop Suite 100 Suite 100, Palmer, AK 99645-7457. The practice phone is (907) 707-1333.

Dr. Sollaccio's primary practice is Peninsula Radiation Oncology Center in Palmer, Alaska. Dr. Sollaccio is also affiliated with Mat-Su Regional Medical Center. The medical group on file is Peninsula Radiation Oncology Center. Dmand AI also links Dr. Sollaccio to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sollaccio practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Sollaccio's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Sollaccio is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Sollaccio's licenses on file in 3 states: Florida, Alaska and Alabama.

Dmand AI lists bladder cancer radiation, bone cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation and lymphoma radiation among the conditions Dr. Sollaccio treats.

CMS data shows 4,639 Medicare services from Dr. Sollaccio across 22 procedure codes in 2024, for 195 Medicare patients. Medicare paid $942,610 for them. Every service was in an office.

CMS counts 195 Medicare patients who saw Dr. Sollaccio in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have cancer, and 72% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sollaccio's median patient age at 70, with 43% women.

In 2024, Dr. Sollaccio wrote 16 Medicare Part D claims. 94% of them were for generic drugs.

Dr. Sollaccio accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Sollaccio. Dr. Sollaccio's most frequent co-authors are Tarek M. Mekhail, MD, Michael David Sombeck, MD and Burkhard Weppelmann, MD.

Dmand AI links Dr. Sollaccio to 5 clinical trials, 3 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Neurotoxicity Syndromes. Radiation Therapy Oncology Group sponsors the most, 4.

CMS Open Payments shows 61 general payments to Dr. Sollaccio from 14 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 87% of the total. Tactile Systems Technology Inc paid the most, $13,086.

Dr. Sollaccio graduated from University Of Florida College Of Medicine in 1985.

Dr. Sollaccio is in network with 6 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.